End-of-Life Management. In the mitigation scenarios developed, it is assumed that end-of-life measures require the shortest lead-times and can be initiated as early as 2012, with full implementation in place by 2014. The products and equipment targeted are as follows: ▪ All appliances (domestic refrigerators, freezers and water heaters) ▪ Vending machines and commercial refrigeration equipment ▪ PU Steel-Faced Panels ▪ Other insulating foams used in buildings. For the appliances, vending machines and commercial refrigeration sectors, two scenarios have been assumed, one in which 100% of units are successfully managed (the technical potential) and one in which 50% of appliances are successfully managed. The latter is seen as the more realistic worst-case scenario, although something between the two should be achievable based on European and Japanese experience. For building insulation, the PU Steel-Faced Panel scenario evaluates 100% recovery and destruction (the technical potential) in isolation. This is then combined with 50% recovery from other insulating foams used in buildings. Finally, a more realistic worst- case is modeled where 25% of general building insulation and 50% of panels are assumed to be managed at end-of-life.
End-of-Life Management. Will the manufacturer or designee accept the product back at the end-of-life? (who pays for the transportation of the product may be situation-specific). Yes. Please see Item F in the following attachment regarding Teknion's EXTEND Program.
End-of-Life Management. The EU Directive 2012/19/EC (on Waste Electrical and Electronic Equipment (also known as WEEE II) [27] represents the EU’s latest effort to increase recycling of and reduce waste from electrical and electronic equipment. Under WEEE II, EU Member States must achieve collection rates of 45% beginning in 2016 and collection rates of 65% by 2019. Most important, all categories of electrical and electronic equipment, including medical devices and in vitro medical devices, are subject to WEEE II recovery targets. In order to achieve the recovery targets established in WEEE II, manufactures/producers are required to establish processes and systems to ensure the safe and effective collection and recovery of most electrical and electronic waste. Medical devices such as in vitro diagnostic medical devices, where such devices are expected to be infective prior to end of life, and active implantable medical devices are excluded from the scope of WEEE II. Manufacturers are also encouraged to maximise the use of recoverable and recyclable materials in their products, and to design products in order to facilitate the dismantling and recovery of 16 xxxxx://xxxxxxxxx.xxx.xxx/waste/ Accessed March 14, 2019. 17 xxxxx://xxxxxxxxxxxxx.xxx/5-types-biohazardous-waste/ Accessed March 14, 2019. recyclable materials. Manufacturers are required to appoint an authorised representative in each EU Member State, who is legally responsible for fulfilling the manufacturer’s responsibilities under WEEE II. In addition to the requirements of WEEE II, medical device manufactures may be subject to other EU directives and regulations addressing the control and recycling of electrical and electronic waste. These include for example EU Directive 2011/65/EU on the restriction of the use of hazardous substances (RoHS II) [28].
End-of-Life Management. Supplier will provide to OUTSET, upon OUTSET request , a proactive, reliable and comprehensive life cycle analysis for the procured costed xxxx of materials (“CBOM”), indicating potential obsolescence, supply disruption or market allocations that could interfere with assurance of supply or cost, extending recommendations for component replacement or inventory management strategies to mitigate or retire foreseeable risk. OUTSET may or may not, at its sole discretion, choose to implement such programs.
